Furohype 40 Injection contains Furosemide 40 mg/ml, a fast-acting loop diuretic commonly used for acute edema, congestive heart failure, renal failure, ascites, and hypertension. It works by increasing urine output and promoting the elimination of excess salt and water from the body.
This injection is widely used in ICUs, emergency care, cardiac units, and nephrology departments, making it a critical medicine in hospital-based treatment protocols.
Belonging to the cardiology and nephrology segment, Furosemide 40 mg injection helps in relieving symptoms like shortness of breath, swelling, and fluid retention, improving patient outcomes and comfort.
With consistent demand in healthcare facilities, Furohype 40 Injection is a strong product choice for PCD pharma franchise partners, bulk wholesalers, institutional suppliers, and third-party manufacturers looking to expand their injectable portfolio.
Common side effects include increased urination, dizziness, electrolyte imbalance (such as low potassium, sodium, or magnesium), and dehydration. Less common but serious adverse effects may include hearing disturbances, kidney impairment, low blood pressure, or muscle cramps. Immediate medical attention is required in case of severe weakness, palpitations, or confusion.
Furohype 40 Injection is indicated for the management of edema associated with congestive heart failure, chronic kidney disease, acute renal failure, nephrotic syndrome, and liver cirrhosis. It is also useful in acute pulmonary edema and may be used in hypertensive emergencies when oral therapy is not feasible.
Furohype 40 Injection must be administered only under proper medical supervision. Regular monitoring of electrolytes, blood pressure, and renal function is recommended during therapy. Inform your physician if you are on cardiac medications, steroids, or have diabetes, dehydration, or severe renal conditions.
Store Furohype 40 Injection in a cool and dry place below 25°C, protected from direct light. Keep out of reach of children and do not freeze.